Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
about
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.Small molecules that enhance the catalytic efficiency of HLA-DMAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesAntigenicity and immunogenicity of allogeneic retinal transplantsDisplay technologies: application for the discovery of drug and gene delivery agents.Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.Variations in the electrostatic landscape of class II human leukocyte antigen molecule induced by modifications in the myelin basic protein peptide: a theoretical approach.Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis.Beyond natural antibodies: the power of in vitro display technologies.Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II moleculeDirect visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.Microglia in neurodegeneration: molecular aspects.Transgenic models of autoimmune disease.Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources.Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.Immune tolerance in multiple sclerosis.Dynamic interaction between astrocytes and infiltrating PBMCs in context of neuroAIDSMultiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cellsUptake and presentation of myelin basic protein by normal human B cells.Humanized animal models for autoimmune diseases.The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice.A parallel panning scheme used for selection of a GluA4-specific Fab targeting the ligand-binding domain.Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor.Multiple sclerosis genetics: leaving no stone unturned.Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.Asparaginyl endopeptidase: case history of a class II MHC compartment protease.T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node.MHC class II proteins and disease: a structural perspective.Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?Astrocytes--friends or foes in multiple sclerosis?Vaccination with single chain antigen receptors for islet-derived peptides presented on I-A(g7) delays diabetes in NOD mice by inducing anergy in self-reactiveT-cells.Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivoTargeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange.
P2860
Q24533132-072C091B-00A6-47C3-9D76-CAB0DAA6B83AQ24623411-1190EA8E-1752-41A5-8919-692BE9EE207AQ28080791-89559FFA-B0EA-4016-8F71-210091EE684BQ28361839-C32F7B22-990A-42EB-B1EB-AF7F3E058514Q33264491-780E2FE7-9E78-406D-BB86-ABFB962460C6Q33357299-84FC5126-27EE-4B97-BABD-AC8F92D44EFAQ33398539-6B8DF6A8-505B-493C-AB9B-C58E202EF0B2Q33819182-582F4B11-2BCD-4923-B716-7206170DC550Q33841864-8F3ECAF7-BE04-4992-BE51-81ECC57B67E3Q33947114-77AD3EBA-11F1-44BC-B2C4-BAD01AC48839Q34035564-714A0D13-430A-4E50-B8E2-FF3E725BCF7FQ34349294-32807CAA-7089-4269-8820-525E5152B2EDQ34554029-5D73715A-DBF6-408C-9FAD-96FDB01A2AC0Q34561569-21EA0F5F-AB1B-4D6A-84A0-340F5BFFD40BQ34792611-DB3022CF-E3FB-41E9-82F6-C77E9B9BCD1AQ34923734-626B0EE4-EDBB-4324-9E69-7CCA04CBF9ECQ34942354-1B213B22-4DAC-45FF-8730-6DBC3A465229Q34944392-E2519F97-ADF8-426D-9F7C-6549C898BC9BQ35160777-704B22C5-4677-4790-8AA0-D9048A96DFEFQ35424431-A7594978-6BFD-4E37-8008-CA1691EA9AE2Q35754332-E267168D-1875-47CA-A228-B46B3FB4654FQ35821240-9B4E7DBB-AC0F-4C29-8E28-A64700A257A4Q35891605-E2EFC959-762E-400A-A8D2-7F0E3637EAE1Q35924840-9B915BFF-387A-4E66-9F25-0D001D65C897Q36018234-2A53E8F5-D357-4A09-9844-55C7386AC0D8Q36073479-040C1529-66AF-4318-9F42-5B19D9033611Q36152482-E16B2AC6-0813-4FF5-98A6-69ED8EE1BBADQ36171871-01BDDEA6-2BDD-4AA8-8FE9-FFC10015F22DQ36218461-7D7742FC-B2DF-4587-A208-472ECF6321A6Q36266494-4C01D5E2-AA5B-42D2-8361-FB52806F6D68Q36297606-9D656E2B-431A-4071-87E3-3C50CE8924C0Q36327377-22FD1E72-D72F-442F-B7FA-56983DD80802Q36371218-F4E10F90-0294-49AB-880B-CFE1DE214ABAQ36430136-89793365-82FF-428B-A0F2-16224C909EACQ36432500-E9F837C8-55A2-4966-9C02-EBBB30A7672BQ36878427-27FC873A-16A3-4D00-85B0-3D5756A03DE5Q37042502-5285EC45-B3E6-497D-B6B8-70C616A63E70Q37072087-DA2B72DB-F3BC-4A0E-8A34-D3A61879812EQ37192915-DA0C6131-B614-46A3-A523-3F5D3B6C04ABQ37224874-DAA91D7D-27DD-4E25-A1A5-3C5F8F04ADE4
P2860
Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Visualization of myelin basic ...... n (HLA)-DR2-MBP 85-99 complex.
@ast
Visualization of myelin basic ...... n (HLA)-DR2-MBP 85-99 complex.
@en
type
label
Visualization of myelin basic ...... n (HLA)-DR2-MBP 85-99 complex.
@ast
Visualization of myelin basic ...... n (HLA)-DR2-MBP 85-99 complex.
@en
prefLabel
Visualization of myelin basic ...... n (HLA)-DR2-MBP 85-99 complex.
@ast
Visualization of myelin basic ...... n (HLA)-DR2-MBP 85-99 complex.
@en
P2093
P2860
P921
P356
P1476
Visualization of myelin basic ...... n (HLA)-DR2-MBP 85-99 complex.
@en
P2093
A Svejgaard
B Cannella
B E Hansen
K W Wucherpfennig
M Krogsgaard
P2860
P304
P356
10.1084/JEM.191.8.1395
P407
P50
P577
2000-04-01T00:00:00Z